Showing 1 - 4 results of 4 for search 'Gerwin Huls', query time: 0.01s Refine Results
  1. 1
    K12-ligand-based CAR T cell therapy for CD7-positive T cell malignancies

    K12-ligand-based CAR T cell therapy for CD7-positive T cell malignancies by Nienke Visser, Macarena González-Corrales, Jimena Álvarez-Freile, Maurien G. Pruis, Lena Rockstein, Harm Jan Lourens, Jan Jacob Schuringa, Tom van Meerten, Gerwin Huls, Edwin Bremer

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?

    Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival? by Hester F Lingsma, David van Klaveren, Arjan A van de Loosdrecht, Anna van Rhenen, Otto Visser, Valery E P P Lemmens, Nikki van Leeuwen, Gerwin Huls, Z L Rana Kaplan, Eduardus F M Posthuma, Danielle van Lammeren-Venema, Tjeerd J F Snijders, Catharina H M J van Elssen, Peter A von dem Borne, Nicole M A Blijlevens, Jan J Cornelissen, Marc H G P Raaijmakers, Avinash G Dinmohamed

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet by Adriano Venditti, Raffaele Palmieri, Luca Maurillo, Christoph Röllig, Agnieszka Wierzbowska, David de Leeuw, Fabio Efficace, Antonio Curti, Lok Lam Ngai, Jesse Tettero, Lionel Adès, Antonio Almeida, Lars Bullinger, Mike Dennis, Jordi Esteve, Felicetto Ferrara, Michael Heuser, Gerwin Huls, Michael Lübbert, Priyanka Mehta, Pau Montesinos, Thomas Pabst, Christian Récher, Giuseppe Rossi, Nigel Russell, Jorge Sierra, Reinhard Stauder, Norbert Vey, Roland B. Walter, Eunice Wang, Samantha Nier, Carolina Garcez Martins, Gert Ossenkoppele

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability

    High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability by Diego A. Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, Juan L. Coelho-Silva, Douglas R. Silveira, Dominique Sternadt, Ayşegül Erdem, Bruno Kosa L. Duarte, Prodromos Chatzikyriakou, Lynn Quek, Antonio Bruno Alves-Silva, Fabiola Traina, Sara T. Olalla Saad, Jacobien R. Hilberink, Amanda Moreira-Aguiar, Maria L. Salustiano-Bandeira, Marinus M. Lima, Pedro L. Franca-Neto, Marcos A. Bezerra, Nisha K. van der Meer, Emanuele Ammatuna, Eduardo M. Rego, Gerwin Huls, Jan Jacob Schuringa, Antonio R. Lucena-Araujo

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: